Physicians’ opinions about decision aids for patients considering systemic adjuvant therapy for axillary-node negative breast cancer
O'Connor AM, Llewellyn-Thomas HA, Sawka C, Pinfold SP, To T, Harrison DE. Patient Educ Couns. 1997; 30(2):143-53.
Publications
Spirometry utilization in Ontario: patterns of practice and policy implications
Chan B, Anderson G, Dales RE. CMAJ. 1997; 156(2):169–176.
Patterns of initial management of node-negative breast cancer in two Canadian provinces
Goel V, Olivotto I, Hislop TG, Sawka C, Coldman A, Holowaty EJ. CMAJ. 1997; 156(1):25-35.
Development of an instrument to measure cancer screening knowledge, attitudes and behaviours
Kindree T, Ashbury FD, Goel V, Levy I, Lipskie T, Futcher R. Chronic Dis Can. 1997; 18(4):168-75.
Compliance with practice guidelines for node-negative breast cancer
Olivotto IA, Coldman AJ, Hislop TG, Trevisan CH, Kula J, Goel V, Sawka C. J Clin Oncol. 1997; 15(1):216-22.
The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer
Sawka C, Olivotto I, Coldman A, Goel V, Holowaty E, Hislop TG. Br J Cancer. 1997; 75(10):1534-42.
Coronary artery bypass graft surgery in Ontario and New York State: which rate is right?
Tu JV, Naylor CD, Kumar D, Debuono BA, McNeil BJ, Hannan EL. Ann Intern Med. 1997; 126(1):13-9.
Trauma patient outcome after the Prehospital Trauma Life Support program
Ali J, Adam RU, Gana TJ, Williams JI. J Trauma. 1997; 42(6):1018-21.
Long-term outcomes in blunt trauma: who goes back to work?
Brenneman FD, Redelmeier DA, Boulanger BR, McLellan BA, Culhane JP. J Trauma. 1997; 42(5):778-81.
Coronary bypass mortality rates in Ontario: a Canadian approach to quality assurance in cardiac surgery
Tu JV, Naylor CD. Circulation. 1996; 94(10):2429-33.